Business Context and Reporting Period
This Form 8-K reports on the 2020 Annual Meeting of Stockholders held by vTv Therapeutics Inc. on June 11, 2020. The company is incorporated in Delaware and its Class A common stock trades on the NASDAQ Capital Market under the symbol VTVT. The filing details the outcomes of three specific matters submitted to a vote by security holders.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
The following matters were approved or ratified by stockholders:
- Election of Directors: All six nominees were elected to the Board of Directors for a term expiring at the 2021 annual meeting. Voting results were as follows:
- Jeffrey B. Kindler: 59,531,174 For; 150,874 Withheld.
- John A. Fry: 59,593,955 For; 88,093 Withheld.
- Hersh Kozlov: 59,543,228 For; 138,820 Withheld.
- Paul G. Savas: 59,556,857 For; 125,191 Withheld.
- Noel J. Spiegel: 59,603,564 For; 78,484 Withheld.
- Howard L. Weiner: 59,602,155 For; 79,893 Withheld.
- Equity Plan Amendment: Stockholders approved an amendment to the 2015 Omnibus Equity Incentive Plan to increase the number of authorized shares reserved for issuance.
- Vote Count: 59,156,032 For; 454,594 Against; 71,422 Withheld.
- Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020.
- Vote Count: 65,258,211 For; 328,705 Against; 42,886 Abstain.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It is strictly a disclosure of voting results.
Investor Verification Checklist
- Verify the specific number of additional shares authorized under the amended 2015 Omnibus Equity Incentive Plan, as the filing confirms the approval but does not state the new total.
- Confirm the total number of shares entitled to vote at the meeting to contextualize the "Broker Non-Votes" (5,947,754) recorded for director elections.
- Review the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.